ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,464.62
-0.16%
Dow Jones
39,150.33
0.04%
US Dollar vs MXN
18.1108
0.00%
Brent Oil
84.39
0.00%
Bitcoin
64,074.36
-0.27%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Revvity Inc (RVTY)

  7. Revvity Inc (RVTY) Noticias

RVTY

Revvity (RVTY)

Revvity Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:RVTY
FechaHoraFuenteTítuloSímboloCompañía
20/06/202407:00GlobeNewswire Inc.Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing ResearchNYSE:RVTYRevvity Inc
18/06/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RVTYRevvity Inc
07/06/202409:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RVTYRevvity Inc
31/05/202407:00Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:RVTYRevvity Inc
28/05/202407:00Business WireRevvity to Present at Goldman Sachs Global Healthcare ConferenceNYSE:RVTYRevvity Inc
07/05/202413:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:RVTYRevvity Inc
29/04/202405:00Business WireRevvity Announces Financial Results for the First Quarter of 2024NYSE:RVTYRevvity Inc
25/04/202415:15Business WireRevvity Board Declares Quarterly DividendNYSE:RVTYRevvity Inc
25/04/202407:00Business WireRevvity to Present at BofA Securities 2024 Health Care ConferenceNYSE:RVTYRevvity Inc
24/04/202405:00Business WireRevvity Unveils a New Era of Automated Tuberculosis TestingNYSE:RVTYRevvity Inc
15/04/202405:00Business WireRevvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract PartnersNYSE:RVTYRevvity Inc
04/04/202407:00Business WireRevvity To Hold Earnings Call on Monday, April 29, 2024NYSE:RVTYRevvity Inc
02/04/202405:00Business WirePreliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire SoftwareNYSE:RVTYRevvity Inc
20/03/202416:00Business WireRevvity Files Complaint and Seeks Injunctive Relief Against Cloud Software GroupNYSE:RVTYRevvity Inc
18/03/202405:00Business WireRevvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry CommunicationNYSE:RVTYRevvity Inc
27/02/202413:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:RVTYRevvity Inc
21/02/202407:00Business WireRevvity to Present at Upcoming Investor ConferencesNYSE:RVTYRevvity Inc
14/02/202409:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:RVTYRevvity Inc
12/02/202415:05Business WireRevvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven DecisionsNYSE:RVTYRevvity Inc
01/02/202415:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:RVTYRevvity Inc
01/02/202405:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:RVTYRevvity Inc
01/02/202405:00Business WireRevvity Announces Financial Results for the Fourth Quarter and Full Year of 2023NYSE:RVTYRevvity Inc
25/01/202415:15Business WireRevvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of DirectorsNYSE:RVTYRevvity Inc
09/01/202407:00Business WireRevvity to Hold Earnings Call on Thursday, February 1, 2024;NYSE:RVTYRevvity Inc
19/12/202307:00Business WireRevvity to Present at J.P. Morgan Healthcare ConferenceNYSE:RVTYRevvity Inc
14/11/202307:00Business WireRevvity to Present at Annual Evercore ISI HealthCONx ConferenceNYSE:RVTYRevvity Inc
30/10/202305:00Business WireRevvity Announces Financial Results for the Third Quarter of 2023NYSE:RVTYRevvity Inc
26/10/202307:00Business WireRevvity Debuts Inaugural ESG ReportNYSE:RVTYRevvity Inc
17/10/202305:34IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNYSE:RVTYRevvity Inc
09/10/202307:00Business WireRevvity To Hold Earnings Call on Monday, October 30, 2023NYSE:RVTYRevvity Inc
 Showing the most relevant articles for your search:NYSE:RVTY

Su Consulta Reciente

LSE
59DP
Bpha Fin.4.816%
USOTC
YITYY
YIT OYJ (PK)
EXMO
SOLUSDT
Solana
BIT
NSCIT0005164
Italian Republic
USOTC
VVCVF
VVC Exploration (QB)
TG
A3KMMZ
Nippon Telegraph and Tel...
EU
BE0002802834
Brussels Domestic bond 1...
LSE
BUR2
Burford 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados